1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 31-40 of 80 (Search time: 0.009 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2021The effect of lifestyle intervention on diabetes prevention by ethnicity: A systematic review of intervention characteristics using the TIDieR frameworkChen, M.; Ukke, G.G.; Moran, L.J.; Sood, S.; Bennett, C.J.; Khomami, M.B.; Absetz, P.; Teede, H.; Harrison, C.L.; Lim, S.
2022Recovery of Male Reproductive Function After Ceasing Prolonged Testosterone Undecanoate InjectionsHandelsman, D.J.; Desai, R.; Conway, A.J.; Shankara-Narayana, N.; Stuckey, B.G.; Inder, W.J.; Grossmann, M.; Yeap, B.B.; Jesudason, D.; Ly, L.P.; Bracken, K.; Wittert, G.A.
2023Genes in loci genetically associated with polycystic ovary syndrome are dynamically expressed in human fetal gonadal, metabolic and brain tissues.Azumah, R.; Hummitzsch, K.; Anderson, R.A.; Rodgers, R.J.
2013Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: A multi-ethnic meta-analysis of 45,891 individualsDastani, Z.; Palmer, L.; Visscher, P.M.; Palmer, Lyle John
2015Hyperglycemia potentiates the slowing of gastric emptying induced by exogenous GLP-1Plummer, M.; Jones, K.; Cousins, C.; Trahair, L.; Meier, J.; Chapman, M.; Horowitz, M.; Deane, A.
2016A protein preload enhances the glucose-lowering efficacy of vildagliptin in type 2 diabetesWu, T.; Little, T.; Bound, M.; Borg, M.; Zhang, X.; Deacon, C.; Horowitz, M.; Jones, K.; Rayner, C.
2013Effects of a D-xylose preload with or without sitagliptin on gastric emptying, glucagon-like peptide-1, and postprandial glycemia in type 2 diabetesWu, T.; Bound, M.; Zhao, R.; Standfield, S.; Bellon, M.; Jones, K.; Horowitz, M.; Rayner, C.
2012Obesity is associated with activated and insulin resistant immune cellsViardot, A.; Heilbronn, L.; Samocha-Bonet, D.; Mackay, F.; Campbell, L.; Samaras, K.
2015Sustained effects of a protein 'preload' on glycaemia and gastric emptying over 4 weeks in patients with type 2 diabetes: A randomized clinical trialMa, J.; Jesudason, D.R.; Stevens, J.E.; Keogh, J.B.; Jones, K.L.; Clifton, P.M.; Horowitz, M.; Rayner, C.K.
2013Evaluation of the dual peroxisome proliferator-activated receptor α/γ agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: rationale and design of the AleCardio trialLincoff, M.; Tardif, J.; Neal, B.; Nicholls, S.; Ryden, L.; Schwartz, G.; Malmberg, K.; Buse, J.; Henry, R.; Wedel, H.; Weichert, A.; Cannata, R.; Grobbee, D.

Discover